LBA30 INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line

Nicoletta Colombo, Andrés Poveda, Jalid Sehouli et al.|Annals of Oncology|2020

Cited by 23